NovoCure Ltd $ 169.10 -2.74 (-1.59%)
Volume:
260,821
Avg Vol (1m):
1,127,915
Market Cap $:
17.21 Bil
Enterprise Value $:
16.99 Bil
P/E (TTM):
890.00
P/B:
56.03
NovoCure Ltd News and Headlines -
GuruFocus Articles
Total 0
- 1
- 1
Headlines
Total 38
- 1
- 1
| 2021-01-21 $ 171.84 (-0.31%) | |
11:27am
| |
| 2021-01-15 $ 167.55 (-6.37%) | |
7:34am
| |
| 2020-12-23 $ 171 (0.91%) | |
7:15pm
| Novocure (NVCR) CEO Asaf Danziger Sold $32.7 million of Shares - GuruFocus.com |
| 2020-11-24 $ 119.41 (-11.16%) | |
3:40pm
| Why Novocure Stock Sank Today - www.fool.com |
| 2020-11-12 $ 123.51 (0.82%) | |
2:40pm
| |
| 2020-10-29 $ 123.27 (6.83%) | |
2:40pm
| |
10:05am
| |
| 2020-10-28 $ 115.39 (-3.44%) | |
11:26am
| Healthcare Stock Q3 Earnings Due on Oct 29: NVCR, CRL & More - www.zacks.com |
| 2020-10-19 $ 132.34 (-3.37%) | |
9:16am
| |
| 2020-10-12 $ 134.57 (-2.99%) | |
8:42am
| |
| 2020-10-09 $ 138.72 (7.3%) | |
7:23am
| 3 Large-Cap MedTech Growth Stocks to Buy Amid the Pandemic - www.zacks.com |
| 2020-10-07 $ 127.02 (6.43%) | |
11:11am
| |
| 2020-10-06 $ 119.35 (1.4%) | |
7:15am
| 3 Growth-Focused MedTech Stocks to Buy Amid the COVID-19 Crisis - www.zacks.com |
| 2020-10-02 $ 113.03 (0.6%) | |
10:30am
| Is NovoCure (NVCR) Outperforming Other Medical Stocks This Year? - www.zacks.com |
| 2020-09-21 $ 105.11 (-5.08%) | |
4:15pm
| |
| 2020-09-18 $ 110.74 (1.61%) | |
4:15pm
| |
| 2020-09-16 $ 107.25 (2.67%) | |
5:15pm
| |
| 2020-07-24 $ 67.79 (1.42%) | |
7:15pm
| |
| 2020-07-23 $ 67.79 (1.42%) | |
11:33am
| NovoCure (NVCR) Q2 Earnings Preview: What's in the Cards? - www.zacks.com |
| 2020-07-08 $ 60.97 (2.33%) | |
6:00am
| The 2 Little-Known Growth Stocks I Bought Last Week - www.fool.com |
| 2020-05-13 $ 62.885 (-2.78%) | |
9:25pm
| |
| 2020-04-30 $ 65.8 (-10.52%) | |
2:33pm
| |
9:13am
| |
6:30am
| NovoCure (NVCR) Lags Q1 Earnings and Revenue Estimates - www.zacks.com |
| 2020-04-23 $ 73.06 (1.02%) | |
11:32am
| |
| 2020-04-22 $ 72.32 (2.26%) | |
10:17am
| |
| 2020-04-15 $ 68.07 (-2.73%) | |
5:15pm
| |
| 2020-04-07 $ 64.54 (-6.6%) | |
8:00am
| Medical Services Outlook Bright Amid Coronavirus Crisis - www.zacks.com |
| 2020-02-26 $ 79.45 (-0.72%) | |
5:15pm
| Novocure (NVCR) COO Michael J. Ambrogi Sold $945,271 of Shares - GuruFocus.com |
| 2019-11-26 $ 92 (-0.8%) | |
4:15pm
| Novocure (NVCR) CEO Asaf Danziger Sold $9.8 million of Shares - GuruFocus.com |
| 2019-11-19 $ 88.44 (3.14%) | |
4:15pm
| |
| 2019-11-15 $ 83.98 (1.89%) | |
4:15pm
| |
| 2019-11-13 $ 81.18 (0.46%) | |
5:15pm
| |
| 2019-11-06 $ 77.19 (-0.39%) | |
5:15pm
| |
| 2019-09-27 $ 75.18 (-2.88%) | |
7:15pm
| |
| 2019-09-17 $ 81.81 (3.52%) | |
5:15pm
| |
| 2019-09-13 $ 79.29 (-1.2%) | |
4:59pm
| |
| 2018-06-15 $ 30.9 (-2.37%) | |
11:01am
| |
- 1